ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Cancer 52

Cancer 52 is an active company incorporated on 16 March 2012 with the registered office located in London, Greater London. Cancer 52 was registered 13 years ago.
Status
Active
Active since incorporation
Company No
07994413
Private Limited Company by guarantee without share capital, use of 'Limited' exemption
Age
13 years
Incorporated 16 March 2012
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 16 March 2025 (5 months ago)
Next confirmation dated 16 March 2026
Due by 30 March 2026 (6 months remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Apr31 Mar 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 March 2025
Due by 31 December 2025 (3 months remaining)
Contact
Address
124 City Road
London
EC1V 2NX
England
Address changed on 21 May 2024 (1 year 3 months ago)
Previous address was C/O Teenage Cancer Trust Third Floor 93 Newman Street London W1T 3EZ
Telephone
01923352935
Email
Available in Endole App
People
Officers
13
Shareholders
-
Controllers (PSC)
1
Director • Chief Executive • Australian • Lives in England • Born in Mar 1966
Director • Doctor • British • Lives in England • Born in Nov 1993
Director • Medical Student • British • Lives in England • Born in Oct 1997
Director • Head Of HR & Organisational Development • British • Lives in UK • Born in Aug 1972
Director • Ceo Charity • British • Lives in England • Born in Aug 1950
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
NFP Property Developments Limited
Mr Nicolas Francis Puntis is a mutual person.
Active
Highcliffe Homes Limited
Mr Nicolas Francis Puntis is a mutual person.
Active
Bright Iris Cic
Clare Marie Clifton is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Mar 2024
For period 31 Mar31 Mar 2024
Traded for 12 months
Cash in Bank
£111.65K
Increased by £19.45K (+21%)
Turnover
£230.78K
Increased by £54.18K (+31%)
Employees
1
Same as previous period
Total Assets
£111.65K
Increased by £19.45K (+21%)
Total Liabilities
-£60.74K
Increased by £57.37K (+1702%)
Net Assets
£50.91K
Decreased by £37.92K (-43%)
Debt Ratio (%)
54%
Increased by 50.74% (+1388%)
Latest Activity
Dr Max Brodermann Details Changed
1 Month Ago on 15 Jul 2025
Helen Mary Morement Resigned
3 Months Ago on 14 May 2025
Confirmation Submitted
5 Months Ago on 19 Mar 2025
Ms Yasmin Sheikh Appointed
6 Months Ago on 26 Feb 2025
Ms Willemke Dagmar Droogsma Appointed
6 Months Ago on 26 Feb 2025
Ms Clare Marie Clifton Appointed
6 Months Ago on 26 Feb 2025
Ms Amanda Boughey Appointed
6 Months Ago on 26 Feb 2025
Full Accounts Submitted
9 Months Ago on 27 Nov 2024
Rebecca Porta Resigned
11 Months Ago on 25 Sep 2024
Christopher Walden Resigned
1 Year Ago on 9 Aug 2024
Get Credit Report
Discover Cancer 52's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Director's details changed for Dr Max Brodermann on 15 July 2025
Submitted on 28 Jul 2025
Termination of appointment of Helen Mary Morement as a director on 14 May 2025
Submitted on 19 May 2025
Confirmation statement made on 16 March 2025 with no updates
Submitted on 19 Mar 2025
Appointment of Ms Yasmin Sheikh as a director on 26 February 2025
Submitted on 4 Mar 2025
Appointment of Ms Clare Marie Clifton as a director on 26 February 2025
Submitted on 4 Mar 2025
Appointment of Ms Amanda Boughey as a director on 26 February 2025
Submitted on 4 Mar 2025
Appointment of Ms Willemke Dagmar Droogsma as a director on 26 February 2025
Submitted on 4 Mar 2025
Resolutions
Submitted on 6 Feb 2025
Total exemption full accounts made up to 31 March 2024
Submitted on 27 Nov 2024
Termination of appointment of Rebecca Porta as a director on 25 September 2024
Submitted on 26 Sep 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year